Advances in Charcot-Marie-Tooth disease research: Cellular function of CMT-related proteins, transgenic animal models, and pathomechanisms

Neurobiology of Disease

Volumn 4, Issue 3-4, 1997, Pages 215-220

  Müller, Hans W ^a   Suter, Ueli ^b   Van Broeckhoven, Christine ^c   Haneman, O ^c   Nelis, E ^c   Timmerman, V ^c   Sancho, S ^c   Barrio, L ^c   Bolhuis, P ^c   Dermietzel, R ^c   Frank, M ^c   Gabreels Festen A ^c   Gillen, C ^c   Haites, N ^c   Levi, G ^c   Mariman, E ^c   Martini, R ^c   Nave, K ^c   Rautenstrauss, B ^c   Schachner, M ^c   Schenone, A ^c   Schneider, C ^c   Schroder M ^c   Willecke, K ^c   more..

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; GENETIC SUSCEPTIBILITY; HEREDITARY MOTOR SENSORY NEUROPATHY; HISTOPATHOLOGY; NERVE BIOPSY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; TRANSGENIC ANIMAL;

EID: 0030668164     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1997.0148     Document Type: Article

References (34)

1. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K. V., Suter U. Hypermyelination and demyelinating peripheral neuropathy in pmp22-deficient mice. Nature Genet. 11:1995;274-280.
2. Adlkofer K., Frei R., Neuberg D. H.-H., Zielasek J., Toyka K. V., Suter U. Heterozygous peripheral myelin protein22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J. Neurosci. 17:1997;4662-4671.
3. Anzini P., Neuberg D. H.-H., Schachner M., Nelles E., Willecke K., Zielasek J., Toyka K. V., Suter U., Martini R. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 17:1997;4536-4544.
4. Bruzzone R., White T. W., Scherer S. S., Fischbeck K. H., Paul D. L. Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron. 13:1994;1253-1260.
5. De Jonghe P., Timmerman V., Nelis E., Martin J. J., Van Broeckhoven C. Charcot-Marie-Tooth Disease and related peripheral neuropathies. J. Peripheral Nervous Syst. 1997.
6. Fabbretti E., Edomi P., Brancolini C., Schneider C. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: Its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev. 9:1995;1846-1856.
7. Fruttiger M., Montag D., Schachner M., Martini R. Crucial role of the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur. J. Neurosci. 7:1995;511-515.
8. Gabrëels-Festen A. A. W. M., Bolhuis P. A., Hoogendijk J. E., Valentijn L. J., Eshuis E. J. H. M., Gabriels F. J. M. Charcot-Marie-Tooth disease type 1A: Morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol. 90:1995;645-649.
9. Giese K. P., Martini R., Lemke G., Soriano P., Schachner M. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell. 71:1992;565-576.
10. Gillen G., Gleichmann M., Greiner-Petter R., Zoidl G., Kupfer S., Bosse F., Auer J., Müller H. W. Full-length cloning, expression and cellular localization of rat plasmolipin mRNA, a proteolipid of PNS and CNS. Eur. J. Neurosci. 8:1996;405-414.
11. Hanemann C. O., Gabreels-Festen A. A. A. W., Müller H. W., Stoll G. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages. Brain. 119:1996;1461-1469.
12. Hanemann C. O., Rosenbaum C., Kupfer S., Wosch S., Stoegbauer F., Müller H. W. Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients. Glia. 1997.
13. Huxley C., Passage E., Manson A., Putzu G., Figarellabranger D., Pelissier J. F., Fontes M. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5:1996;563-569.
14. Magyar J. P., Martini R., Ruelicke T., Aguzzi A., Adlkofer K., Dembic Z., Zielasek J., Toyka K. V., Suter U. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16:1996;5351-5360.
15. Magyar J. P., Ebensperger C., Schaeren-Wiemers N., Suter U. Myelin and lymphocyte protein (MAL/MVP17/VIP17) and plasmolipin are members of an extended gene family. Gene. 189:1997;269-275.
16. Martini R., Zielasek J., Toyka K. V., Giese K. P., Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nature Genet. 11:1995;281-286.
17. Montag D., Giese K. P., Bartsch U., Martini R., Lang Y., Bluthmann H., Karthigasan J., Kirschner D. A., Wintergerst E. S., Nave K. A., Zielasek J., Toyka K. V., Lipp H.-P., Schachner M. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron. 13:1994;229-246.
18. Nelis E., Van Broeckhoven C. Estimation of the mutation frequencies in CMT1 and HNNP: A European collaborative study. Eur. J. Hum. Genet. 4:1996;25-33.
19. Nelles E., Bützler C., Jung D., Temme A., Gabriel H.-D., Dahl U., Traub O., Stümpel F., Jungermann K., Zielasek J., Toyka K. V., Dermietzel R., Willecke K. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32 deficient mice. Proc. Natl. Acad. Sci. USA. 93:1996;9565-9570.
20. Schaeren-Wiemers N., Valenzuela D. M., Frank M., Schwab M. E. Characterization of a rat gene, rMAL, encoding a protein with four hydrophobic domains in central and peripheral myelin. J. Neurosci. 15:1995;5753-5764.
21. Schenone A., Nobbio L., Mandich P., Bellone E., Abbruzzese M., Aymar F., Mancardi G. L., Windebank A. J. Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology. 48:1997;445-449.
22. Scherer S. S., Deschenes S. M., Xu Y.-i., Grinspan J. B., Fischbeck K. H., Paul D. L. Connexin32 is a myelin-related protein in the PNS and CNS. J. Neurosci. 15:1995;8281-8294.
23. Scherer S. S., Bone L. J., Dechenes S. M., Fishbeck K. H., Balice-Gordon R. The role of the gap junction protein connexin32 in the myelin sheath. Cell Biology and Pathology of Myelin: Evolving Concepts and Therapeutic Approaches. 1997;Plenum, New York. p. 83-102.
24. Sereda M., Griffiths I., Pühlhofer A., Stewart H., Rossner M. J., Zimmermann F., Magyar J. P., Schneider A., Hund E., Meinck H.-M., Suter U., Nave K. A. A rat transgenic model for Charcot-Marie-Tooth disease. Neuron. 16:1996;1049-1060.
25. Shapiro L., Doyle J. P., Hensley P., Colman D. R., Hendrickson W. A. Crystal structure of the extracellular domain from P0 the major structural protein of peripheral nerve myelin. Neuron. 17:1996;435-449.
26. Sóhl G., Gillen C., Bosse F., Gleichmann M., Müller H. W., Willecke K. A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur. J. Cell. Biol. 69:1996;267-275.
27. Spray D. C., Dermietzel R. X-linked dominant Charcot-Marie-Tooth disease and other potential gap-junction diseases of the nervous system. Trends Neurosci. 18:1995;256-262.
28. Suter U., Snipes G. J. Biology and genetics of hereditary motor and sensory neuropathies. Annu. Rev. Neurosci. 18:1995;45-75.
29. Thomas P. K., Marques T. I., Davis M. B., Sweeney M. G., King R. H. M., Bradley J. L., Muddle J. R., Tyson J., Malcolm S., Harding A. E. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain. 120:1997;465-478.
30. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A. B., Seitanidou T., Babinet C., Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature. 371:1994;796-799.
31. Warner L. E., Hilz M. J., Appel S. H., Killian J. M., Kolodny E. H., Karpati G., Carpenter S., Watters G. V., Wheeler C., Witt D., Bodell A., Nelis E., Van Broeckhoven C., Lupsky J. R. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth Type 1B, Dejerine-Sottas, and Congenital Hypomyelination. Neuron. 17:1996;451-460.
32. Windebank A. J. Inherited recurrent neuropathy. Dyck P. J., Thomas P. K., Griffin J. W., Low P. A., Poduslo J. F. Peripheral Neuropathy. 1993;1094-1136 Saunders, Philadelphia.
33. Zoidl G., Blass-Kampmann S., D'Urso D., Schmalenbach C., Müller H. W. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J. 14:1995;1122-1128.
34. Zoidl G., D'Urso D., Blass-Kampmann S., Schmalenbach C., Kuhn R., Müller H. W. Influence of elevated expression of rat wild type PMP22 and its mutant PMP22 (Trembler) on cell growth of NIH3T3 fibroblasts. Cell Tissue Res. 287:1997;459-470.